[1] WENG S C,LIN C S,TARNG D C,et al.Physical frailty and long-term mortality in older people with chronic heart failure with preserved and reduced ejection fraction:a retrospective longitudinal study[J].BMC Geriatrics,2021,21(1):721-723. [2] BASHKIN A,SALEH W A,SHEHADEH M,et al.Subclinical hypothyroidism or isolated high TSH in hospitalized patients with chronic heart-failure and chronic renal-failure[J].Sci Rep,2021,11(1):687-689. [3] 吕晓燕,胡小菁.通痹宁心汤联合美托洛尔对缺血性心肌病心力衰竭患者心率变异性,跨室壁复极离散度和主要心脏不良事件的影响[J].现代中西医结合杂志,2019,28(29):677-679. [4] 王彦斌,陈小平,任素芳,等.麝香保心丸联合曲美他嗪对缺血性心肌病心力衰竭患者的临床疗效[J].中国药物与临床,2019,19(3):68-69. [5] 中华医学会心血管病学分会心力衰竭学组,中国医师协会心力衰竭专业委员会,中华心血管病杂志编辑委员会.中国心力衰竭诊断和治疗指南2018[J].中华心力衰竭和心肌病杂志,2018,21(4):30-31. [6] 中华医学会心血管病学分会介入心脏病学组,中华医学会心血管病学分会动脉粥样硬化与冠心病学组,中国医师协会心血管内科医师分会血栓防治专业委员会,等.稳定性冠心病诊断与治疗指南[J].中华心血管病杂志,2018,46(9):15-19. [7] AVI S,MICHAEL G,MAHMOUD S,et al.Arrhythmic burden among asymptomatic patients with ischemic cardiomyopathy and an implantable cardioverter-defibrillator[J].Heart Rhythm,2019,16(6):813-819. [8] THADANI U.Trimetazidine for stable and unstable ischemic heart diseases and for heart failure:Is its routine use justified from available data?[J].Int J Cardiol,2020,30(2):45-46. [9] 杨勇,刘庚,常宇锋.不同剂量曲美他嗪对高脂血症合并冠心病病人血管内皮功能的影响[J].中西医结合心脑血管病杂志,2018,16(10):1460-1642. [10] 倪秋明,林苗,王军,等.不同剂量曲美他嗪治疗冠心病心力衰竭的疗效研究[J].心脑血管病防治,2019,19(2):1479-1481. [11] BEHZADI A H,AMOOZGAR B,JAIN S,et al.Trimetazidine reduces contrast-induced nephropathy in patients with renal insufficiency undergoing coronary angiography and angioplasty:A systematic review and meta-analysis (PRISMA)[J].Medicine,2021,49(5):664-669. [12] MCCALLUM M W,HTMB C,MSKM D,et al.Relation of kidney function decline and NT-proBNP with risk of mortality and readmission in acute decompensated heart failure[J].Am J Med,2020,133(1):115-122.
2022, Vol. 39 
